Hospital
Greater Baltimore Medical Center, INC.
Greater Baltimore Medical Center, INC. was paid $792K by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 39% of everything it billed.
33Billing provider infoGREATER BALTIMORE MEDICAL CENTER, INC.
BALTIMORE, MD 21204
BALTIMORE, MD 21204
33aNPI1255372397assigned 06/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$792K
24GClaims68,121
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#38 of 69
Median peer was paid$870K
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,302 | $13K | |
| 2019 | 11,522 | $82K | |
| 2020 | 5,322 | $96K | |
| 2021 | 9,720 | $119K | |
| 2022 | 11,595 | $157K | |
| 2023 | 10,793 | $195K | |
| 2024incomplete | 7,867 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 39% | 3,047 | 2,846 | $307K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 2,595 | 2,427 | $170K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 14% | 3,341 | 2,511 | $109K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.9% | 601 | 559 | $70K |
| G0378 | Hospital observation service, per hour | 6.9% | 91 | 84 | $55K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.4% | 7,257 | 6,479 | $35K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.3% | 301 | 165 | $18K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.9% | 281 | 272 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 644 | 574 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 697 | 639 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 803 | 772 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 6,242 | 4,961 | $1K |
46 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 479 | $856.26 |
| 84484 | <1% | 2,983 | $792.33 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 460 | $780.87 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 26 | $706.11 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,694 | $598.64 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,961 | $483.77 |
| 71045 | Radiologic examination, chest; single view | <1% | 498 | $195.01 |
| 82553 | <1% | 1,886 | $192.91 | |
| 84703 | <1% | 594 | $188.46 | |
| 81001 | <1% | 1,628 | $143.88 | |
| 83605 | <1% | 1,208 | $140.54 | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,456 | $132.17 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 381 | $128.81 |
| 82947 | <1% | 4,841 | $102.88 | |
| 82550 | <1% | 1,521 | $63.92 | |
| 83880 | <1% | 68 | $63.65 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 46 | $53.70 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 26 | $52.70 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,308 | $51.31 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 95 | $46.68 |
| 87400 | <1% | 13 | $41.27 | |
| 85610 | <1% | 999 | $36.13 | |
| A9270 | Non-covered item or service | <1% | 5,014 | $33.45 |
| 83690 | <1% | 459 | $28.52 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 39 | $23.23 |
| 85730 | <1% | 118 | $16.97 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 925 | $15.35 |
| 83735 | <1% | 302 | $14.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 381 | $3.43 |
| 85027 | <1% | 347 | $2.53 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 194 | $0.23 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,229 | $0.09 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 706 | $0.00 |
| 87077 | 0% | 193 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 59 | $0.00 |
| 87040 | 0% | 31 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 383 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 28 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 92 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 45 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 41 | $0.00 |
| 84100 | 0% | 86 | $0.00 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 67 | $0.00 |
| 81003 | 0% | 83 | $0.00 | |
| 87186 | 0% | 178 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELLIS, JOHN (SENIOR VP CORPORATE STRATEGY)
| Provider | Location | Paid |
|---|---|---|
| Greater Baltimore Medical Center, INC. | Baltimore, MD | $9.39M |
| Farmington Oral & Facial Surgery P a | Farmington, ME | $1.22M |
| Alliance Urgent Care, INC | Hemet, CA | $1.05M |
| DR John P Ellis Clinic Podiatry LLC | Fairview Park, OH | $241K |
| Blair and Ellis P.A. | El Paso, TX | $52K |
| Northeastern Pennsylvania Cardiology Associates LLP | Plains, PA | $37K |
| Ekg Associates of Wyoming Valley LLP | Wilkes Barre, PA | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.